Impaired glucose metabolism in patients with ischaemic heart disease;Häufigkeit der störungen des glukosestoffwechsels bei patienten mit koronarer herzkrankheit

Clinical Research in Cardiology

Volumn 95, Issue 1 SUPPL., 2006, Pages

  Leschke, M ^a   Schwenk, B ^a   Bollinger, C ^a   Faehling, M ^a  

^a KLINIKUM ESSLINGEN   (Germany)

Author keywords

Diabetes; Glucose control; Glycaemia; Impaired glucose tolerance; Ischaemic heart disease; Mortality; Myocardial infarction

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATECHOLAMINE RELEASE; DEATH; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; MORTALITY; REVIEW;

BLOOD GLUCOSE; DEATH, SUDDEN, CARDIAC; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; MYOCARDIAL INFARCTION; REGISTRIES; RISK FACTORS; SEX FACTORS;

EID: 31544446843     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-1118-8     Document Type: Review

References (25)

1. Abbate A, Biondi-Zoccai GGL (2005) The difficult task of glycaemic control in diabetics with acute coronary syndromes: finding the way to normoglycaemia acoiding both hyper-and hypoglycaemia. Europ Heart J 26:1245-1248
2. American Diabetes Association (2004) Clinical practice recommendations. Position statement screening for type 2 diabetes. Diabetes Care 27(Suppl 1):S11-S14
3. Biondi-Zoccai GL, Abbate A, Linzog G (2003) Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol 41:1071-1077
4. Bonora E, Muggeo M (2001) Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologica 44:2107-2114
5. Erkens JA, Herings RM, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG (2002) Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus. J Clin Epidemiol 55:345-349
6. Gradaus F, Leschke M, Jax TW, Schannwell CM, Schoebel FC, Strauer BE (1998) Behandlung der koronaren Herzkrankheit bei Patienten mit Diabetes mellitus. Dtsch Med Wochenschr 123:1419-1425
7. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234
8. Hanefeld M (2002) Primäre Prävention des Typ-2 Diabetes. Dtsch Med Wochenschr 127:951-952
9. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE (2002) Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diab Care 25:1129-1134
10. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689
11. Jouven X, Lematre RN, Rea TD, Sotoodehnia N, Empana J-P, Siscovick DS (2005) Diabetes, Glucose level, and risk of sudden cardiac death. Eur Heart J, 26 (in press) online Publikation 24. 6. 2005, doi: 10.1093/eurheartj/ehi376
12. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease: the Framingham study 241:2033-2038
13. Leschke M (2003) Verhütet eine gezielte Therapie von Typ-2-Diabetes kardiovaskuläre Ereignisse? Med Klin 98(Suppl I):12-16
14. Meier JJ, Deifuß S, Gallwitz B, Klamann A, Schmiegel W, Nauck MA (2002) Einfluss einer eingeschränkten Glukosetoleranz auf das Langzeitüberleben nach akutem Myokardinfarkt. Dtsch Med Wochenschr 127:1123-1129
15. Norhammer A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140-2144
16. Rathmann W, Icks A, Haastert B, Giani G, Löwel H, Mielck A (2002) Undiagnosed diabetes mellitus among patients with prior myocardial infarction. Z Kardiol 91:620-625
17. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twist JW, Heine RJ, Visser FC (2004) Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164:982-988
18. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, Markiewicz W, Aronson D (2005) Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction. A prospective study. Circulation 111:754-760
19. Taubert G, Winkelmann BR, Schleiffer T, Marz W, Winkler R, Gok R, Klein B, Schneider S, Boehm BO (2003) Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 145:285-291
20. Tenenbaum A, Motro M, Schwammenthal E, Fisman EZ (2004) Macrovascular complications of metabolic syndrome: an early intervention is imperative. Int J Cardiol 97:167-172
21. Terkelsen CJ, Lassen JF, Norgaard BL, Gerdes JC, Jensen T, Gotsche LBH, Nielsen TT, Hennig RA (2005) Mortality rates in patients with ST-elevations vs non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 26:18-26
22. The DECODE Study Group (2001) Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397-404
23. UKPDS 33 (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
24. Vegt F de, Nijpels G, Dekker JM et al (2000) Similar 9-year mortality risks and reproducibility for the world health organisation and american diabetes association glucose tolerance categories. Diabetes Care 23:40-44
25. Wylie G, Hungin AP, Neely I (2002) Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions. BMJ 18:1190